Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$19.43 - $35.36 $3.66 Million - $6.67 Million
-188,512 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$29.41 - $51.23 $41,850 - $72,900
1,423 Added 0.76%
188,512 $6.82 Million
Q1 2020

May 12, 2020

BUY
$19.54 - $55.47 $53,852 - $152,875
2,756 Added 1.5%
187,089 $6.12 Million
Q4 2019

Feb 12, 2020

BUY
$10.16 - $28.14 $1.87 Million - $5.19 Million
184,333 New
184,333 $5.03 Million

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $442M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.